Aishwarya_Jain

Aishwarya_Jain

Devyani International is a service provider to KFC and Costa Coffee, one of the leading retail food business. CMP 130 SL 105 Target 155/160 Note: Sales rise 124.43% to Rs 516.08 crore. Net profit of Devyani International reported to Rs 45.70 crore in the quarter ended September 2021 as against net loss of Rs 66.70 crore during the previous quarter ended...

Aishwarya_Jain

Buy Urja Global at 7.35 SL 6.5 Target 9.9 Duration 3 Months Long Term Bullish as its a Power Sector Stock. Earnings are also nearby.

Aishwarya_Jain Updated 

United Spirits was bought on 26 Oct at 835 SL 805 Target 925 Duration 3 Months It reversed from the recent support price of 810-812 (Fibonacci) Earnings are also going to come, which can be a booster for the price of United Spirits.

Aishwarya_Jain

Buy IRTC at CMP of 4300 (we bought on 2 Oct 2021 at 4100) SL 3700 Target 5100+ Note: Share split is on 28 Oct in 5:1 ratio

Aishwarya_Jain Updated 

National Aluminium was bought at 91. CMP 105+ SL trailed to 95 Target 150+ Duration 3 Months

Aishwarya_Jain Updated 

Tata Consumer is a Tata Group Company share, havig good market share and good potential to grow as well. Buy at 825 SL 795 Target 885 Duration 3 Months.

Aishwarya_Jain

After last dividend payout, the stock went high to 470. Currently it is trading at a fair price of 447. Buy above 449 till 450 SL 435 Target 480 Buy and hold for a 6-7% return in a month. Note: Earnings are also nearby. This will have a positive impact as mostly PSU are giving positive results.

Aishwarya_Jain Updated 

Dilip Buildcon is having a price flag breakout. One can buy and hold for the long term. CMP 580 SL 500 Target 700 Duration 3 Months.

Aishwarya_Jain Updated 

Tata Power has seen a multiyear Price Breakout, supported by huge volumes. The stock has witnessed a tremendous increase in interest from the market, mostly supported by the renewable energy boost. Its a must buy for all the portfolio. Also, fundamentally very strong, one can buy and hold for the long term portfolio, and Buy in every dip of 10-15%. CMP...

Aishwarya_Jain

RVNL Bought at 31 SL 29 Target 40 Target Hit Next Target 80+ Duration 3 Months

Aishwarya_Jain

Canara Bank is trading at a very attractive price with good future forcast. Buy & Hold at CMP 193+ (We bought at 175) SL 125 Target 275 Fundamental Snippets : Market Cap - ₹ 35,112 Cr. Current Price - ₹ 194 High / Low - ₹ 195 / 84.4 Stock P/E - 9.63 Book Value - ₹ 344 Dividend Yield - 0.00 % ROCE - 5.35 % ROE - 5.58 % Face Value - ₹ 10.0 Debt to equity -...

Aishwarya_Jain

ACC is trading near the support price trend at 2250 One can buy at these levels. SL 2130 Target 2490 Duration 3 Months

Aishwarya_Jain Updated 

Buy National Alluminium CMP 91-92 SL 85 Target 100 A very good triangle breakout is under formation.

Aishwarya_Jain

Glenmark Pharma is having a good Trend reversal if it closes above breakout price of 515. CMP 513 Swing Trade: Buy Glenmark Pharma at 515 SL 485 Target 575 Duration 2-3 Months.

Aishwarya_Jain Updated 

Coal India is near a triangle pattern breakout. CMP 148 Buy above 155 SL 130 Target 205 Duration 3-4 Months Fundamental Snapshot: PE Ratio - 6.64 Debt Equity Ratio - 0.16 ROCE - 46.1% ROE - 37% Dividend Yield - 10.16% Operating Profit & EPS - Rising YoY

Aishwarya_Jain Updated 

Bajaj Auto is trading at 3750 SL 3650 Target 4250 Duration 3 Months Fundamental Snippet: PE - 19 PEG Ratio - 5.28 ROCE - 25.4 ROE - 19.8 Debt Equity - 0 Promoter Holding - 53.7 Inventory Turnover - 15.4

Aishwarya_Jain

Redington is forming a Triangle Breakout Pattern. Buy at 145 SL 135 Target 175 Duration 3 Months Fundamental Snippets: Market Cap - ₹ 11,278 Cr. Current Price - ₹ 144 High / Low - ₹ 179 / 57.2 Stock P/E - 12.4 Book Value - ₹ 63.2 Dividend Yield - 2.63 % ROCE - 21.2 % ROE - 16.4 % Face Value - ₹ 2.00 Debt to equity - 0.13 Price to book value - 2.29 PEG Ratio -...

Aishwarya_Jain

Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. Its product portfolio spreads over major therapeutic areas such as oncology, gastroenterology, anti-diabetic, cardiovascular, pain management, and gynecology. The company was founded by Mark Bosco Saldanha on April 16, 1992 and is headquartered in Mumbai,...